Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-07

AUTHORS

Daniel J. Ellenberger, Dave A. Miller, Sandra U. Kucera, Robert O. Williams

ABSTRACT

Vemurafenib is a poorly soluble, low permeability drug that has a demonstrated need for a solubility-enhanced formulation. However, conventional approaches for amorphous solid dispersion production are challenging due to the physiochemical properties of the compound. A suitable and novel method for creating an amorphous solid dispersion, known as solvent-controlled coprecipitation, was developed to make a material known as microprecipitated bulk powder (MBP). However, this approach has limitations in its processing and formulation space. In this study, it was hypothesized that vemurafenib can be processed by KinetiSol into the same amorphous formulation as MBP. The KinetiSol process utilizes high shear to rapidly process amorphous solid dispersions containing vemurafenib. Analysis of the material demonstrated that KinetiSol produced amorphous, single-phase material with acceptable chemical purity and stability. Values obtained were congruent to analysis conducted on the comparator material. However, the materials differed in particle morphology as the KinetiSol material was dense, smooth, and uniform while the MBP comparator was porous in structure and exhibited high surface area. The particles produced by KinetiSol had improved in-vitro dissolution and pharmacokinetic performance for vemurafenib compared to MBP due to slower drug nucleation and recrystallization which resulted in superior supersaturation maintenance during drug release. In the in-vivo rat pharmacokinetic study, both amorphous solid dispersions produced by KinetiSol exhibited mean AUC values at least two-fold that of MBP when dosed as a suspension. It was concluded that the KinetiSol process produced superior dosage forms containing vemurafenib with the potential for substantial reduction in patient pill burden. More... »

PAGES

1957-1970

Identifiers

URI

http://scigraph.springernature.com/pub.10.1208/s12249-018-0988-1

DOI

http://dx.doi.org/10.1208/s12249-018-0988-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1101528674

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29541940


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calorimetry, Differential Scanning", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemistry, Pharmaceutical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Crystallization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Desiccation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dosage Forms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Compounding", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Stability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Particle Size", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Powders", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Solubility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vemurafenib", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "X-Ray Diffraction", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The University of Texas at Austin", 
          "id": "https://www.grid.ac/institutes/grid.89336.37", 
          "name": [
            "DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA", 
            "College of Pharmacy, The University of Texas at Austin, 1 University Station, Campus Mail Code A1902, 78712, Austin, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ellenberger", 
        "givenName": "Daniel J.", 
        "id": "sg:person.0600654057.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600654057.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miller", 
        "givenName": "Dave A.", 
        "id": "sg:person.0700304357.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700304357.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kucera", 
        "givenName": "Sandra U.", 
        "id": "sg:person.0601407165.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601407165.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas at Austin", 
          "id": "https://www.grid.ac/institutes/grid.89336.37", 
          "name": [
            "College of Pharmacy, The University of Texas at Austin, 1 University Station, Campus Mail Code A1902, 78712, Austin, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Williams", 
        "givenName": "Robert O.", 
        "id": "sg:person.01211140532.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211140532.32"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ejpb.2007.11.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000069156"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/03639045.2014.971027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000190499"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2013.05.061", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000453340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/s12249-015-0417-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000672990", 
          "https://doi.org/10.1208/s12249-015-0417-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1408868", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000859328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-009-9852-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001516558", 
          "https://doi.org/10.1007/s11095-009-9852-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-009-9852-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001516558", 
          "https://doi.org/10.1007/s11095-009-9852-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.23425", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002093860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/prp2.113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002214116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd3847", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004232546", 
          "https://doi.org/10.1038/nrd3847"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2007.12.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006661742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2009.09.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007013343"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(83)90064-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007844718"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(83)90064-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007844718"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ddtec.2011.10.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009081965"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ddtec.2011.10.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009081965"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.carbpol.2013.09.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010117913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0939-6411(00)00076-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010715816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0939-6411(96)00037-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010784506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-010-0130-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012311683", 
          "https://doi.org/10.1007/s11095-010-0130-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-010-0130-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012311683", 
          "https://doi.org/10.1007/s11095-010-0130-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc1302338", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012716185"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2013.09.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013760714"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/acschembio.5b00174", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015977540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600540202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016640642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2006.07.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019673284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2012.08.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021424172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0040517512468815", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022221523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0040517512468815", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022221523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd3579", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022770880", 
          "https://doi.org/10.1038/nrd3579"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.28168", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025164898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2011.08.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027073494"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.22074", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027233167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600831211", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031087388"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.2012.73", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031895836", 
          "https://doi.org/10.1038/clpt.2012.73"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0378-5173(98)00400-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033324116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.24541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036349671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1016212804288", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037126380", 
          "https://doi.org/10.1023/a:1016212804288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1020390422785", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037263988", 
          "https://doi.org/10.1023/a:1020390422785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-319-42609-9_9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037380114", 
          "https://doi.org/10.1007/978-3-319-42609-9_9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/js980403l", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037849804"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.21650", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038163237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/anie.200806299", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038857996"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/anie.200806299", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038857996"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2012.08.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040358693"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.addr.2016.02.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041048322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.addr.2016.02.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041048322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/s12248-009-9144-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043278894", 
          "https://doi.org/10.1208/s12248-009-9144-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/s12249-010-9431-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046529857", 
          "https://doi.org/10.1208/s12249-010-9431-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4939-1598-9_6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046538574", 
          "https://doi.org/10.1007/978-1-4939-1598-9_6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(95)00033-f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047257017"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.apsb.2013.10.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051406957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/s12249-015-0393-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051714926", 
          "https://doi.org/10.1208/s12249-015-0393-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.21367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052662120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1016292416526", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052847671", 
          "https://doi.org/10.1023/a:1016292416526"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2012.07.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053536579"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01926230701226575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058308389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01926230701226575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058308389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/s12249-017-0861-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091836467", 
          "https://doi.org/10.1208/s12249-017-0861-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.32.15_suppl.3516", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111106124"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-07", 
    "datePublishedReg": "2018-07-01", 
    "description": "Vemurafenib is a poorly soluble, low permeability drug that has a demonstrated need for a solubility-enhanced formulation. However, conventional approaches for amorphous solid dispersion production are challenging due to the physiochemical properties of the compound. A suitable and novel method for creating an amorphous solid dispersion, known as solvent-controlled coprecipitation, was developed to make a material known as microprecipitated bulk powder (MBP). However, this approach has limitations in its processing and formulation space. In this study, it was hypothesized that vemurafenib can be processed by KinetiSol into the same amorphous formulation as MBP. The KinetiSol process utilizes high shear to rapidly process amorphous solid dispersions containing vemurafenib. Analysis of the material demonstrated that KinetiSol produced amorphous, single-phase material with acceptable chemical purity and stability. Values obtained were congruent to analysis conducted on the comparator material. However, the materials differed in particle morphology as the KinetiSol material was dense, smooth, and uniform while the MBP comparator was porous in structure and exhibited high surface area. The particles produced by KinetiSol had improved in-vitro dissolution and pharmacokinetic performance for vemurafenib compared to MBP due to slower drug nucleation and recrystallization which resulted in superior supersaturation maintenance during drug release. In the in-vivo rat pharmacokinetic study, both amorphous solid dispersions produced by KinetiSol exhibited mean AUC values at least two-fold that of MBP when dosed as a suspension. It was concluded that the KinetiSol process produced superior dosage forms containing vemurafenib with the potential for substantial reduction in patient pill burden.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1208/s12249-018-0988-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1023420", 
        "issn": [
          "1530-9932"
        ], 
        "name": "AAPS PharmSciTech", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol\u00ae Processing", 
    "pagination": "1957-1970", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "08b92c287ea6bf1d1c4a39cc69e7add0a380f25da395fdbfe2ccbf58c4861898"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29541940"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100960111"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1208/s12249-018-0988-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1101528674"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1208/s12249-018-0988-1", 
      "https://app.dimensions.ai/details/publication/pub.1101528674"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000361_0000000361/records_54011_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1208%2Fs12249-018-0988-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1208/s12249-018-0988-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1208/s12249-018-0988-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1208/s12249-018-0988-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1208/s12249-018-0988-1'


 

This table displays all metadata directly associated to this object as RDF triples.

341 TRIPLES      21 PREDICATES      100 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1208/s12249-018-0988-1 schema:about N01df92645cbc4d1896b19559a7cdda08
2 N06b5eb5144a44b34b46ab1821b1e26e4
3 N1393c83e30c449158b561779c7af6d3c
4 N21602737bf2b49ebae9470276f6f31f0
5 N25a9262854c74580b9ae03cfe4a44240
6 N2a88135e844c41c598dc578a8112ee54
7 N30df760fc1824e658b1a25c40d531f0a
8 N362795106738482287b4401e98f75657
9 N3b336bf51b7b4ee985ba903c5b92285d
10 N41136bc6f5e44cdd80ed9a8c5bf4761e
11 N46ec8cde14644822ad1ff4a8496a4b9c
12 N4ffa032dcc034f909b96d3ab90767b49
13 N546dacad8b8a4bde87acf25decd6d735
14 N5e1dab0ac2044bfb978720c830000ccf
15 N72f021fe24c2437caa09e39df46a7240
16 N799bc7d50d24419fb0cacd3d64ad7af1
17 Nbceba441ea764c47a82221d4d7812e42
18 Nd71ef2d8d24e4e5a9e77d9fa4e995333
19 Ne29b572ca88943cba1d4666658bfb95e
20 anzsrc-for:03
21 anzsrc-for:0306
22 schema:author Nb236593ed75e492ea0f19ecc75ee612c
23 schema:citation sg:pub.10.1007/978-1-4939-1598-9_6
24 sg:pub.10.1007/978-3-319-42609-9_9
25 sg:pub.10.1007/s11095-009-9852-z
26 sg:pub.10.1007/s11095-010-0130-x
27 sg:pub.10.1023/a:1016212804288
28 sg:pub.10.1023/a:1016292416526
29 sg:pub.10.1023/a:1020390422785
30 sg:pub.10.1038/clpt.2012.73
31 sg:pub.10.1038/nrd3579
32 sg:pub.10.1038/nrd3847
33 sg:pub.10.1208/s12248-009-9144-x
34 sg:pub.10.1208/s12249-010-9431-y
35 sg:pub.10.1208/s12249-015-0393-y
36 sg:pub.10.1208/s12249-015-0417-7
37 sg:pub.10.1208/s12249-017-0861-7
38 https://doi.org/10.1002/anie.200806299
39 https://doi.org/10.1002/ijc.28168
40 https://doi.org/10.1002/jps.21367
41 https://doi.org/10.1002/jps.21650
42 https://doi.org/10.1002/jps.22074
43 https://doi.org/10.1002/jps.23425
44 https://doi.org/10.1002/jps.24541
45 https://doi.org/10.1002/jps.2600540202
46 https://doi.org/10.1002/jps.2600831211
47 https://doi.org/10.1002/prp2.113
48 https://doi.org/10.1016/0378-5173(83)90064-9
49 https://doi.org/10.1016/0378-5173(95)00033-f
50 https://doi.org/10.1016/j.addr.2016.02.005
51 https://doi.org/10.1016/j.apsb.2013.10.001
52 https://doi.org/10.1016/j.carbpol.2013.09.017
53 https://doi.org/10.1016/j.ddtec.2011.10.002
54 https://doi.org/10.1016/j.ejpb.2007.11.004
55 https://doi.org/10.1016/j.ejpb.2009.09.007
56 https://doi.org/10.1016/j.ejpb.2013.09.007
57 https://doi.org/10.1016/j.ijpharm.2006.07.011
58 https://doi.org/10.1016/j.ijpharm.2007.12.017
59 https://doi.org/10.1016/j.ijpharm.2011.08.007
60 https://doi.org/10.1016/j.ijpharm.2012.07.015
61 https://doi.org/10.1016/j.ijpharm.2012.08.031
62 https://doi.org/10.1016/j.ijpharm.2012.08.032
63 https://doi.org/10.1016/j.ijpharm.2013.05.061
64 https://doi.org/10.1016/s0378-5173(98)00400-1
65 https://doi.org/10.1016/s0939-6411(00)00076-x
66 https://doi.org/10.1016/s0939-6411(96)00037-9
67 https://doi.org/10.1021/acschembio.5b00174
68 https://doi.org/10.1021/js980403l
69 https://doi.org/10.1056/nejmc1302338
70 https://doi.org/10.1056/nejmoa1408868
71 https://doi.org/10.1080/01926230701226575
72 https://doi.org/10.1177/0040517512468815
73 https://doi.org/10.1200/jco.2014.32.15_suppl.3516
74 https://doi.org/10.3109/03639045.2014.971027
75 schema:datePublished 2018-07
76 schema:datePublishedReg 2018-07-01
77 schema:description Vemurafenib is a poorly soluble, low permeability drug that has a demonstrated need for a solubility-enhanced formulation. However, conventional approaches for amorphous solid dispersion production are challenging due to the physiochemical properties of the compound. A suitable and novel method for creating an amorphous solid dispersion, known as solvent-controlled coprecipitation, was developed to make a material known as microprecipitated bulk powder (MBP). However, this approach has limitations in its processing and formulation space. In this study, it was hypothesized that vemurafenib can be processed by KinetiSol into the same amorphous formulation as MBP. The KinetiSol process utilizes high shear to rapidly process amorphous solid dispersions containing vemurafenib. Analysis of the material demonstrated that KinetiSol produced amorphous, single-phase material with acceptable chemical purity and stability. Values obtained were congruent to analysis conducted on the comparator material. However, the materials differed in particle morphology as the KinetiSol material was dense, smooth, and uniform while the MBP comparator was porous in structure and exhibited high surface area. The particles produced by KinetiSol had improved in-vitro dissolution and pharmacokinetic performance for vemurafenib compared to MBP due to slower drug nucleation and recrystallization which resulted in superior supersaturation maintenance during drug release. In the in-vivo rat pharmacokinetic study, both amorphous solid dispersions produced by KinetiSol exhibited mean AUC values at least two-fold that of MBP when dosed as a suspension. It was concluded that the KinetiSol process produced superior dosage forms containing vemurafenib with the potential for substantial reduction in patient pill burden.
78 schema:genre research_article
79 schema:inLanguage en
80 schema:isAccessibleForFree false
81 schema:isPartOf Nbff0a1c5d44a406c84cd5b82b6c24b85
82 Nffcc7c9da6b04ffdb2296a60c664d01e
83 sg:journal.1023420
84 schema:name Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing
85 schema:pagination 1957-1970
86 schema:productId N8f37c46ef2fb43098ae3764166b75f02
87 N9258bc58d7d345c183a628c8aedd6ee5
88 Nb9be59a9172b4b34a99568a8fd1bf74c
89 Nd059d861f9ea43e8ad5cee5647b20dd0
90 Nf1dd17b230ff4e2e9609b90a36328779
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101528674
92 https://doi.org/10.1208/s12249-018-0988-1
93 schema:sdDatePublished 2019-04-11T12:15
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N497fe83dedc4462ab9741474c88b3b54
96 schema:url https://link.springer.com/10.1208%2Fs12249-018-0988-1
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N007b516408cd4c5ebe48f5bb2e526f5b rdf:first sg:person.0601407165.07
101 rdf:rest N74e8df4c612c43b0967da9424b2e1a9d
102 N01df92645cbc4d1896b19559a7cdda08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Calorimetry, Differential Scanning
104 rdf:type schema:DefinedTerm
105 N06b5eb5144a44b34b46ab1821b1e26e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Antineoplastic Agents
107 rdf:type schema:DefinedTerm
108 N1393c83e30c449158b561779c7af6d3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Dosage Forms
110 rdf:type schema:DefinedTerm
111 N21602737bf2b49ebae9470276f6f31f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Solubility
113 rdf:type schema:DefinedTerm
114 N25a9262854c74580b9ae03cfe4a44240 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Indoles
116 rdf:type schema:DefinedTerm
117 N2a88135e844c41c598dc578a8112ee54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Crystallization
119 rdf:type schema:DefinedTerm
120 N30df760fc1824e658b1a25c40d531f0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Rats, Sprague-Dawley
122 rdf:type schema:DefinedTerm
123 N362795106738482287b4401e98f75657 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Vemurafenib
125 rdf:type schema:DefinedTerm
126 N3b336bf51b7b4ee985ba903c5b92285d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Rats
128 rdf:type schema:DefinedTerm
129 N41136bc6f5e44cdd80ed9a8c5bf4761e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Drug Compounding
131 rdf:type schema:DefinedTerm
132 N46ec8cde14644822ad1ff4a8496a4b9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Chemistry, Pharmaceutical
134 rdf:type schema:DefinedTerm
135 N497fe83dedc4462ab9741474c88b3b54 schema:name Springer Nature - SN SciGraph project
136 rdf:type schema:Organization
137 N499204bbe1b04bbc90dc5711c7b65204 schema:name DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA
138 rdf:type schema:Organization
139 N4ffa032dcc034f909b96d3ab90767b49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Male
141 rdf:type schema:DefinedTerm
142 N546dacad8b8a4bde87acf25decd6d735 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Particle Size
144 rdf:type schema:DefinedTerm
145 N5e1dab0ac2044bfb978720c830000ccf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Desiccation
147 rdf:type schema:DefinedTerm
148 N71cb095d81e646e59eaa9ab6193681bd schema:name DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA
149 rdf:type schema:Organization
150 N72f021fe24c2437caa09e39df46a7240 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Sulfonamides
152 rdf:type schema:DefinedTerm
153 N74e8df4c612c43b0967da9424b2e1a9d rdf:first sg:person.01211140532.32
154 rdf:rest rdf:nil
155 N799bc7d50d24419fb0cacd3d64ad7af1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Drug Stability
157 rdf:type schema:DefinedTerm
158 N8f37c46ef2fb43098ae3764166b75f02 schema:name nlm_unique_id
159 schema:value 100960111
160 rdf:type schema:PropertyValue
161 N9258bc58d7d345c183a628c8aedd6ee5 schema:name doi
162 schema:value 10.1208/s12249-018-0988-1
163 rdf:type schema:PropertyValue
164 Nb236593ed75e492ea0f19ecc75ee612c rdf:first sg:person.0600654057.17
165 rdf:rest Nd1e5f8b40ca74838b49de244773af402
166 Nb9be59a9172b4b34a99568a8fd1bf74c schema:name dimensions_id
167 schema:value pub.1101528674
168 rdf:type schema:PropertyValue
169 Nbceba441ea764c47a82221d4d7812e42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Animals
171 rdf:type schema:DefinedTerm
172 Nbff0a1c5d44a406c84cd5b82b6c24b85 schema:issueNumber 5
173 rdf:type schema:PublicationIssue
174 Nd059d861f9ea43e8ad5cee5647b20dd0 schema:name readcube_id
175 schema:value 08b92c287ea6bf1d1c4a39cc69e7add0a380f25da395fdbfe2ccbf58c4861898
176 rdf:type schema:PropertyValue
177 Nd1e5f8b40ca74838b49de244773af402 rdf:first sg:person.0700304357.60
178 rdf:rest N007b516408cd4c5ebe48f5bb2e526f5b
179 Nd71ef2d8d24e4e5a9e77d9fa4e995333 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name X-Ray Diffraction
181 rdf:type schema:DefinedTerm
182 Ne29b572ca88943cba1d4666658bfb95e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Powders
184 rdf:type schema:DefinedTerm
185 Nf1dd17b230ff4e2e9609b90a36328779 schema:name pubmed_id
186 schema:value 29541940
187 rdf:type schema:PropertyValue
188 Nffcc7c9da6b04ffdb2296a60c664d01e schema:volumeNumber 19
189 rdf:type schema:PublicationVolume
190 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
191 schema:name Chemical Sciences
192 rdf:type schema:DefinedTerm
193 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
194 schema:name Physical Chemistry (incl. Structural)
195 rdf:type schema:DefinedTerm
196 sg:journal.1023420 schema:issn 1530-9932
197 schema:name AAPS PharmSciTech
198 rdf:type schema:Periodical
199 sg:person.01211140532.32 schema:affiliation https://www.grid.ac/institutes/grid.89336.37
200 schema:familyName Williams
201 schema:givenName Robert O.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211140532.32
203 rdf:type schema:Person
204 sg:person.0600654057.17 schema:affiliation https://www.grid.ac/institutes/grid.89336.37
205 schema:familyName Ellenberger
206 schema:givenName Daniel J.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600654057.17
208 rdf:type schema:Person
209 sg:person.0601407165.07 schema:affiliation N499204bbe1b04bbc90dc5711c7b65204
210 schema:familyName Kucera
211 schema:givenName Sandra U.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601407165.07
213 rdf:type schema:Person
214 sg:person.0700304357.60 schema:affiliation N71cb095d81e646e59eaa9ab6193681bd
215 schema:familyName Miller
216 schema:givenName Dave A.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700304357.60
218 rdf:type schema:Person
219 sg:pub.10.1007/978-1-4939-1598-9_6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046538574
220 https://doi.org/10.1007/978-1-4939-1598-9_6
221 rdf:type schema:CreativeWork
222 sg:pub.10.1007/978-3-319-42609-9_9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037380114
223 https://doi.org/10.1007/978-3-319-42609-9_9
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/s11095-009-9852-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1001516558
226 https://doi.org/10.1007/s11095-009-9852-z
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/s11095-010-0130-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012311683
229 https://doi.org/10.1007/s11095-010-0130-x
230 rdf:type schema:CreativeWork
231 sg:pub.10.1023/a:1016212804288 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037126380
232 https://doi.org/10.1023/a:1016212804288
233 rdf:type schema:CreativeWork
234 sg:pub.10.1023/a:1016292416526 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052847671
235 https://doi.org/10.1023/a:1016292416526
236 rdf:type schema:CreativeWork
237 sg:pub.10.1023/a:1020390422785 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037263988
238 https://doi.org/10.1023/a:1020390422785
239 rdf:type schema:CreativeWork
240 sg:pub.10.1038/clpt.2012.73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031895836
241 https://doi.org/10.1038/clpt.2012.73
242 rdf:type schema:CreativeWork
243 sg:pub.10.1038/nrd3579 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022770880
244 https://doi.org/10.1038/nrd3579
245 rdf:type schema:CreativeWork
246 sg:pub.10.1038/nrd3847 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004232546
247 https://doi.org/10.1038/nrd3847
248 rdf:type schema:CreativeWork
249 sg:pub.10.1208/s12248-009-9144-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043278894
250 https://doi.org/10.1208/s12248-009-9144-x
251 rdf:type schema:CreativeWork
252 sg:pub.10.1208/s12249-010-9431-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1046529857
253 https://doi.org/10.1208/s12249-010-9431-y
254 rdf:type schema:CreativeWork
255 sg:pub.10.1208/s12249-015-0393-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1051714926
256 https://doi.org/10.1208/s12249-015-0393-y
257 rdf:type schema:CreativeWork
258 sg:pub.10.1208/s12249-015-0417-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000672990
259 https://doi.org/10.1208/s12249-015-0417-7
260 rdf:type schema:CreativeWork
261 sg:pub.10.1208/s12249-017-0861-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091836467
262 https://doi.org/10.1208/s12249-017-0861-7
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1002/anie.200806299 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038857996
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1002/ijc.28168 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025164898
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1002/jps.21367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052662120
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1002/jps.21650 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038163237
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1002/jps.22074 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027233167
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1002/jps.23425 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002093860
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1002/jps.24541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036349671
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1002/jps.2600540202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016640642
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1002/jps.2600831211 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031087388
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1002/prp2.113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002214116
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1016/0378-5173(83)90064-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007844718
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/0378-5173(95)00033-f schema:sameAs https://app.dimensions.ai/details/publication/pub.1047257017
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/j.addr.2016.02.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041048322
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1016/j.apsb.2013.10.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051406957
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1016/j.carbpol.2013.09.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010117913
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1016/j.ddtec.2011.10.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009081965
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1016/j.ejpb.2007.11.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000069156
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1016/j.ejpb.2009.09.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007013343
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1016/j.ejpb.2013.09.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013760714
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1016/j.ijpharm.2006.07.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019673284
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1016/j.ijpharm.2007.12.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006661742
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1016/j.ijpharm.2011.08.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027073494
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1016/j.ijpharm.2012.07.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053536579
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1016/j.ijpharm.2012.08.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021424172
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1016/j.ijpharm.2012.08.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040358693
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1016/j.ijpharm.2013.05.061 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000453340
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1016/s0378-5173(98)00400-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033324116
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1016/s0939-6411(00)00076-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010715816
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1016/s0939-6411(96)00037-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010784506
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1021/acschembio.5b00174 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015977540
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1021/js980403l schema:sameAs https://app.dimensions.ai/details/publication/pub.1037849804
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1056/nejmc1302338 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012716185
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1056/nejmoa1408868 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000859328
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1080/01926230701226575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058308389
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1177/0040517512468815 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022221523
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1200/jco.2014.32.15_suppl.3516 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111106124
335 rdf:type schema:CreativeWork
336 https://doi.org/10.3109/03639045.2014.971027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000190499
337 rdf:type schema:CreativeWork
338 https://www.grid.ac/institutes/grid.89336.37 schema:alternateName The University of Texas at Austin
339 schema:name College of Pharmacy, The University of Texas at Austin, 1 University Station, Campus Mail Code A1902, 78712, Austin, Texas, USA
340 DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA
341 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...